Page 814 - Veterinary Immunology, 10th Edition
P. 814

tests have not been standardized, and there is no consensus
  VetBooks.ir  regarding the interpretation of these antibody titers. Even animals

               that lack detectable antibodies may have significant resistance to
               disease. Nor is there much information available regarding long-

               term immunity on mucosal surfaces. In general, immunity against
               feline panleukopenia, canine distemper, canine parvovirus, and
               canine adenovirus is considered to be relatively long-lasting (>5
               years). On the other hand, immunity to feline rhinotracheitis, feline

               calicivirus, and Chlamydophila is believed to be relatively short. One
               problem in making these statements is variability among individual
               animals and among different types of vaccine. Thus recombinant
               canine distemper vaccines may induce immunity of shorter

               duration than conventional, modified live vaccines. There may be a
               great difference between the shortest and longest duration of
               immunological memory within a group of animals. Duration of
               immunity studies are confounded by the fact that many older

               animals have increased innate resistance. Different vaccines within
               a category may differ significantly in their composition, and
               although all vaccines may induce immunity in the short term, it
               cannot be assumed that all confer long-term immunity.

               Manufacturers use different master seeds and different methods of
               antigen preparation. The level of immunity required for most of
               these diseases is unknown. A significant difference exists between
               the minimal level of immunity required to protect most animals

               and the level of immunity required to ensure protection of all
               animals.



               TABLE 25.1
               Estimated Minimum Duration of Immunity (DOI) of Select

               Commercially Available Canine Vaccine Antigens


                Vaccine                            Estimated Minimum DOI Estimated Relative Efficacy (%)
                Essential
                Canine distemper (modified live virus [MLV]) >7 yr     >90
                Canine distemper (recombinant [R])  >1 yr              >90
                Canine parvovirus-2 (MLV)          >7 yr               >90
                Canine adenovirus-2 (MLV)          >7 yr               >90
                Rabies virus (killed [K])          >3 yr               >85
                Optional
                Canine coronavirus (K or MLV)      N/A                 N/A
                Canine parainfluenza (MLV)         >3 yr               >80
                Bordetella bronchiseptica (ML)     <1 yr               <70
                Leptospira canicola (K)            <1 yr               <50



                                                         814
   809   810   811   812   813   814   815   816   817   818   819